Extract notice to the Minister
Omlyclo (urticaire - nouvelle teneur)
Common name / Subject : omalizumab (biosimilaire)
Name of the manufacturer : Celltrion
Form : Sol. Inj. S.C. (ser)
Dosage : 150 mg/ml (0,5 ml)
Name of the manufacturer : Celltrion
Form : Sol. Inj. S.C. (ser)
Dosage : 150 mg/ml (0,5 ml)
Indication : Urticaire chronique idiopathique
INESSS' Recommendation
Inscription - Sous conditions
Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception (2025-11-06)
Evaluation published on October 29, 2025
INESSSid: 28511
Recevable on August 29, 2025